MSD2 Antibody

Shipped with Ice Packs
In Stock

Description

Molecular Function and Clinical Relevance

MDM2 (Mouse Double Minute 2 Homolog) is an E3 ubiquitin ligase that regulates the tumor suppressor p53 by promoting its degradation via the proteasome . Overexpression of MDM2 is linked to tumorigenesis in soft tissue sarcomas, osteosarcomas, and breast cancers . Immunohistochemical (IHC) detection of MDM2 protein overexpression aids in diagnosing liposarcomas and low-grade osteosarcomas, particularly when differentiating them from benign lesions .

Key mechanisms:

  • Binds p53’s transactivation domain, inhibiting its transcriptional activity .

  • Amplification of the MDM2 gene on chromosome 12q13-15 correlates with poor prognosis .

Antibody Characteristics and Validation

Commercial MDM2 antibodies (e.g., clones BSB-64, SMP14, IF2) are validated for IHC, western blot (WB), and immunofluorescence (IF).

CloneIsotypeApplicationsSpecificitySource
BSB-64Mouse IgG1IHC (FFPE/frozen)Nuclear staining in liposarcoma Bio SB
SMP14Mouse IgGWB, IP, IFCross-reacts with cytokeratins BD Biosci.
IF2Mouse IgGIHC, WBDetects ~90 kDa MDM2 and isoforms Thermo Fisher

Antibody validation includes:

  • IHC: Strong nuclear staining in liposarcoma, testicular cancer, and cervical tissues .

  • WB: Detects endogenous MDM2 at ~90 kDa in MCF-7 and HeLa lysates .

  • Preabsorption controls: Reduced fluorescence after preincubation with recombinant MDM2 .

3.1. Diagnostic Applications

  • Liposarcoma: Co-overexpression of MDM2 and CDK4 distinguishes well-differentiated/dedifferentiated liposarcomas from benign adipose tumors .

  • Osteosarcoma: MDM2 IHC improves differentiation of low-grade osteosarcomas from fibrous lesions .

3.2. Autoimmunity Link

A study detected anti-MDM2 autoantibodies in 23.3% of systemic lupus erythematosus (SLE) patients versus 4.3% in healthy controls .

GroupAnti-MDM2+Frequency
SLE10/4323.3%*
Healthy3/694.3%
*P<0.05P < 0.05

These autoantibodies showed nuclear staining in Hep-2 cells and correlated with anti-p53 antibodies .

Limitations and Cross-Reactivity

  • Clone SMP14 cross-reacts with cytokeratins 6, 14, and 16 in cytoplasmic compartments .

  • False negatives may occur in tissues with low MDM2 expression (e.g., colon cancer) .

Product Specs

Buffer
Preservative: 0.03% ProClin 300; Constituents: 50% Glycerol, 0.01M PBS, pH 7.4
Form
Liquid
Lead Time
14-16 weeks (made-to-order)
Synonyms
MSD2 antibody; At3g56350 antibody; F18O21_310 antibody; Superoxide dismutase [Mn] 2 antibody; mitochondrial antibody; EC 1.15.1.1 antibody; Protein MANGANESE SUPEROXIDE DISMUTASE 2 antibody; AtMSD2 antibody
Target Names
MSD2
Uniprot No.

Target Background

Function
This antibody neutralizes superoxide anion radicals, reactive oxygen species (ROS) normally produced within cells that are toxic to biological systems.
Database Links

KEGG: ath:AT3G56350

STRING: 3702.AT3G56350.1

UniGene: At.34942

Protein Families
Iron/manganese superoxide dismutase family
Subcellular Location
Mitochondrion matrix.

Q&A

What is MSD2 and why are antibodies against it important in research?

MSD2 is a manganese-bound superoxide dismutase that uniquely localizes to the apoplast in plants due to its secretory peptide. Unlike other SOD family members such as MSD1 (which localizes to mitochondria), MSD2 operates in the apoplastic space and plays a crucial role in ROS metabolism pathways generated by NADPH oxidase . The protein contains specific active sites where H60, H108, D197, and H201 form an active pocket around the manganese cation (Mn²⁺) .

Antibodies against MSD2 are essential research tools for:

  • Detecting and quantifying MSD2 protein expression in wild-type and transgenic plants

  • Investigating subcellular localization, particularly in confirming apoplastic positioning

  • Studying post-translational modifications that regulate MSD2 activity

  • Examining protein-protein interactions in ROS signaling pathways

  • Comparing MSD2 expression levels under different environmental conditions

These antibodies enable researchers to understand MSD2's role in plant development, particularly root morphogenesis and responses to varying light conditions as demonstrated in recent studies .

How can researchers confirm the specificity of MSD2 antibodies?

Confirming antibody specificity is critical for reliable MSD2 research. The following methodological approaches are recommended:

  • Genetic controls: Compare antibody reactivity between wild-type plants and msd2 mutant/knockdown lines, where absence or reduction of signal in mutants confirms specificity

  • Recombinant protein validation: Test reactivity against purified recombinant MSD2 protein alongside negative controls

  • Peptide competition assay: Pre-incubate antibody with the immunizing peptide before application to samples; specific signals should be blocked

  • Cross-reactivity assessment: Test reactivity against related SOD family members, particularly MSD1, which shares structural similarities with MSD2

  • Immunoprecipitation with mass spectrometry: Confirm that immunoprecipitated proteins are indeed MSD2

  • Tagged protein controls: Verify detection of MSD2-tagged proteins (e.g., MSD2-mCherry) in transgenic plants

Research has shown that immunoblotting with an anti-mCherry antibody effectively confirmed the identity of MSD2-mCherry bands on native-PAGE gels, validating both protein expression and enzymatic activity .

What are the optimal conditions for using MSD2 antibodies in Western blotting?

For optimal Western blotting results with MSD2 antibodies, researchers should consider the following methodological parameters:

Sample preparation:

  • Extract proteins using buffer containing 50 mM Tris-HCl (pH 7.5), 150 mM NaCl, 0.5% Triton X-100, and protease inhibitor cocktail

  • For apoplastic MSD2, perform specific cell wall protein extraction procedures

  • Load 20-50 μg total protein per lane for standard detection

  • Include reducing agent (DTT or β-mercaptoethanol) in sample buffer

Gel electrophoresis and transfer:

  • Use 12% SDS-PAGE gels for optimal resolution of MSD2 (approximately 25-30 kDa)

  • For activity assays, employ native-PAGE conditions without SDS

  • Transfer to PVDF membranes at 100V for 1 hour or 30V overnight at 4°C

  • Verify transfer efficiency with Ponceau S staining

Antibody incubation:

  • Block with 5% low-fat dry milk in TBST (0.1% Tween-20) for 1 hour at room temperature

  • For phosphorylation-specific detection, use 3% BSA instead of milk

  • Dilute primary antibodies 1:1,000 to 1:5,000 in blocking buffer

  • Incubate primary antibody overnight at 4°C with gentle agitation

  • Use appropriate secondary antibodies at 1:5,000 to 1:10,000 dilution for 1 hour at room temperature

Detection and quantification:

  • Apply ECL or fluorescent detection systems based on required sensitivity

  • For quantification, use software like ImageJ to measure band intensity

  • Include at least three biological replicates for statistical validity

  • Compare results across different extraction methods to ensure complete protein recovery

Studies have demonstrated successful detection of MSD2-mCherry via both denaturing SDS-PAGE and native-PAGE, indicating the versatility of antibody-based detection approaches .

What controls should be included when performing immunoprecipitation with MSD2 antibodies?

Rigorous controls are essential for reliable immunoprecipitation experiments with MSD2 antibodies:

Negative controls:

  • IgG control: Use non-specific IgG from the same species as the MSD2 antibody

  • Genetic control: Perform parallel immunoprecipitation with samples from msd2 mutant plants

  • No-antibody control: Process samples through the entire protocol without adding primary antibody

  • Pre-immune serum: When available, use serum collected before immunization

Positive controls:

  • Input sample: Load 5-10% of starting material alongside immunoprecipitated samples

  • Known interactors: Include antibodies against established MSD2-interacting proteins

  • Tagged protein control: For studies with tagged MSD2, include controls expressing the tag alone

Validation approaches:

  • Western blotting: Confirm immunoprecipitated protein identity with MSD2 antibodies

  • Activity assays: Verify that immunoprecipitated MSD2 retains enzymatic activity using NBT staining

  • Mass spectrometry: Identify co-immunoprecipitated proteins and confirm MSD2 sequence

  • Competition assays: Demonstrate specificity by adding excess immunizing peptide

Research has demonstrated successful immunoprecipitation of MSD2-mCherry using anti-mCherry antibodies, followed by functional analysis of SOD activity and assessment of post-translational modifications like tyrosine nitration .

How do researchers distinguish between MSD2 and other SOD family members using antibodies?

Distinguishing MSD2 from other SOD family members requires careful consideration of antibody selection and experimental design:

Antibody design considerations:

  • Target unique epitopes not shared with other SOD isoforms

  • Select regions with minimal sequence homology to related proteins, particularly MSD1

  • Consider using antibodies against MSD2-specific post-translational modifications

  • When possible, develop antibodies against the signal peptide unique to MSD2

Experimental approaches:

  • Combine antibody detection with subcellular fractionation to separate mitochondrial (MSD1) and apoplastic (MSD2) pools

  • Verify antibody specificity using recombinant MSD1 and MSD2 proteins

  • Use knockout/knockdown lines for each SOD family member as controls

  • Compare reactivity patterns across different tissues and developmental stages

Biochemical discrimination:

  • Exploit differential sensitivity to inhibitors (KCN and H₂O₂) in activity assays

  • MSD2 activity, like MSD1, is resistant to both KCN and H₂O₂, distinguishing it from CSD and FSD isoforms

  • Assess optimal pH conditions (MSD2 shows strongest activity at pH 8.0)

  • Consider differences in post-translational modifications between SOD family members

Structural analysis reveals that while MSD2 shares spatial similarity with MSD1, they differ in amino acid composition at the active site, providing potential targets for specific antibody development .

How can MSD2 antibodies be used to study post-translational modifications, particularly tyrosine nitration?

MSD2 undergoes significant post-translational modifications that regulate its activity, with tyrosine nitration being particularly important. Methodological approaches using antibodies include:

Tyrosine nitration analysis:

  • Immunoprecipitate MSD2 using specific antibodies or tag-based approaches

  • Perform Western blotting with anti-nitrotyrosine antibodies (1:3,000 dilution in TBST with 3% low-fat dry milk)

  • Compare nitration levels between untreated samples and those exposed to peroxynitrite

  • For site-specific studies, generate Y68F mutants, as Y68 has been identified as a key nitration site in MSD2

Quantitative assessment:

  • Measure the ratio of nitrated to non-nitrated MSD2 using quantitative immunoblotting

  • Correlate nitration levels with SOD activity measurements

  • Track changes in nitration patterns under different stress conditions

  • Compare wild-type MSD2 with site-directed mutants (e.g., Y68F) to confirm specificity

Structural impacts:

  • Examine how nitration affects MSD2 activity using immunoprecipitated protein

  • Analyze the distance between Y68 side chain and the Mn²⁺ within the active site before and after nitration

  • Assess how peroxynitrite-induced nitration inhibits MSD2 activity in a concentration-dependent manner

  • Use site-directed mutagenesis (Y68F) to confirm the functional impact of Y68 nitration

Research has shown that peroxynitrite treatment inhibits MSD2 activity by 20% at 100 μM and 40% at 200 μM concentrations, while Y68F mutation significantly reduces this inhibitory effect, confirming Y68 as the primary target for nitration .

What methodologies enable the use of MSD2 antibodies for studying protein localization across different plant tissues?

MSD2 exhibits specific localization patterns that can be studied using antibody-based approaches:

Immunohistochemistry optimization:

  • Fix tissues in 4% paraformaldehyde with vacuum infiltration

  • Section tissues at 5-10 μm thickness for optimal antibody penetration

  • Perform antigen retrieval using citrate buffer (pH 6.0) heating

  • Block with 5% BSA or normal serum in PBS with 0.1% Triton X-100

  • Incubate with primary MSD2 antibodies (1:100-1:500) overnight at 4°C

  • Detect using fluorescent secondary antibodies for high-resolution imaging

Subcellular localization analysis:

  • Perform plasmolysis treatments to distinguish cell wall from plasma membrane localization

  • Use propidium iodide counterstaining for cell boundary visualization

  • Compare localization of native MSD2 (via antibodies) with MSD2-fluorescent protein fusions

  • Implement confocal microscopy with z-stack acquisition for three-dimensional analysis

Tissue-specific expression patterns:

  • Compare expression across different tissues (roots, leaves, stems, flowers)

  • Examine developmental stage-specific expression patterns

  • Investigate how environmental conditions (particularly light vs. dark) affect expression

  • Correlate protein localization with promoter-reporter studies

Research has demonstrated that MSD2-mCherry localizes primarily to the apoplast of epidermal cells, with fluorescence remaining associated with the cell wall after plasmolysis . In guard cells, MSD2 shows both vacuolar and apoplastic localization . When the signal peptide is deleted (MSD2ΔSP), the protein accumulates in the cytoplasm instead .

How can researchers use MSD2 antibodies to investigate the relationship between protein expression and enzymatic activity?

Understanding the correlation between MSD2 protein levels and SOD activity requires specialized methodological approaches:

Combined activity and immunodetection:

  • Separate proteins using native-PAGE to preserve enzymatic activity

  • Perform in-gel SOD activity assays using Nitroblue tetrazolium (NBT) and flavin staining

  • Transfer replicate gels to membranes for immunoblotting with MSD2 antibodies

  • Correlate activity bands with immunodetection signals to confirm identity

Quantitative correlation analysis:

  • Immunoprecipitate MSD2 using specific antibodies

  • Measure SOD activity of the immunoprecipitated fraction

  • Quantify protein amount via Western blotting

  • Calculate specific activity (activity per unit protein)

  • Compare activity across different tissues, developmental stages, or stress conditions

Inhibitor and modification studies:

  • Test the effects of specific inhibitors (KCN, H₂O₂) on immunoprecipitated MSD2 activity

  • Determine optimal pH conditions for enzymatic function (pH 8.0 for MSD2)

  • Assess how post-translational modifications affect the activity-to-protein ratio

  • Compare wild-type enzyme with site-directed mutants

Genetic complementation:

  • Express MSD2 in msd2 mutant backgrounds and quantify both protein levels and activity

  • Correlate restoration of phenotypes with biochemical measurements

  • Test structure-function relationships using modified MSD2 variants

Research demonstrates that MSD2 activity can be successfully measured following native-PAGE separation and verified by immunoblotting with tag-specific antibodies . The activity is resistant to KCN and H₂O₂ inhibition, confirming its identity as a manganese superoxide dismutase .

What experimental approaches can be used to study the effects of environmental conditions on MSD2 expression and activity?

MSD2 expression and activity are regulated by environmental conditions, particularly light. Comprehensive experimental designs should include:

Treatment design:

  • Compare plants grown in continuous light, dark, or varying photoperiods

  • Apply different stress treatments (oxidative stress, drought, pathogen exposure)

  • Implement time-course sampling after treatment initiation

  • Analyze multiple developmental stages and tissue types

  • Include wild-type and msd2 mutant genotypes for comparative analysis

Protein expression analysis:

  • Extract proteins from specific tissues following controlled treatments

  • Quantify MSD2 levels via Western blotting with specific antibodies

  • Normalize to appropriate loading controls

  • Compare expression patterns across different tissues and treatments

  • Perform subcellular fractionation to track potential relocalization

Functional correlation:

  • Measure SOD activity using native-PAGE with NBT staining

  • Compare activity patterns with protein expression levels

  • Assess post-translational modifications under different conditions

  • Correlate molecular data with physiological responses

  • Analyze ROS distribution using specific dyes (HPF for H₂O₂, DHE for O₂⋅⁻)

Phenotypic analysis:

  • Document morphological differences between wild-type and msd2 mutants

  • Measure root meristem and elongation zone sizes under different conditions

  • Quantify cell number and size in specific tissues

  • Correlate phenotypes with molecular and biochemical data

Research has shown that MSD2 expression in roots is regulated by light conditions, with higher expression in dark-grown seedlings . Consistent with this expression pattern, msd2 mutants exhibit an increased elongation zone size in dark-grown seedlings compared to wild-type plants, suggesting MSD2 participates in skotomorphogenesis by limiting the elongation zone under dark conditions .

How can researchers use antibodies to investigate MSD2's role in oxidative stress responses?

To understand MSD2's function in oxidative stress responses, researchers can employ several antibody-dependent approaches:

ROS localization in relation to MSD2:

  • Perform dual labeling with MSD2 antibodies and ROS-specific dyes

  • Compare ROS distribution patterns between wild-type and msd2 mutant plants

  • Use HPF to detect H₂O₂ and DHE to detect O₂⋅⁻ in relation to MSD2 localization

  • Analyze how environmental stresses alter both MSD2 localization and ROS patterns

Stress treatment studies:

  • Expose plants to various oxidative stress conditions (high light, drought, pathogens)

  • Immunoprecipitate MSD2 using specific antibodies

  • Measure SOD activity of immunoprecipitated protein under different stress conditions

  • Assess post-translational modifications (particularly tyrosine nitration) in response to stress

Inhibitor studies:

  • Apply specific inhibitors of MSD2 activity (e.g., peroxynitrite)

  • Use antibodies to confirm MSD2 protein levels remain unchanged while activity decreases

  • Correlate biochemical modifications with reduced activity

  • Compare phenotypic effects with those observed in msd2 mutants

Interaction studies:

  • Immunoprecipitate MSD2 and identify interacting proteins by mass spectrometry

  • Investigate how protein-protein interactions change under oxidative stress conditions

  • Perform co-immunoprecipitation studies to confirm specific interactions

  • Use proximity ligation assays to visualize interactions in situ

Research has demonstrated that peroxynitrite treatment inhibits MSD2 activity through tyrosine nitration, particularly at residue Y68 . The Y68F mutation significantly reduces this inhibitory effect, highlighting the importance of this residue in redox-based regulation of MSD2 activity .

What are the challenges in detecting apoplastic MSD2 and how can they be addressed?

Detecting apoplastic proteins like MSD2 presents unique challenges that require specific methodological solutions:

Extraction challenges and solutions:

  • Challenge: Low abundance in standard protein extracts

  • Solution: Implement specialized apoplastic protein extraction methods using vacuum infiltration followed by centrifugation to collect apoplastic fluid

  • Challenge: Strong association with cell wall components

  • Solution: Use sequential extraction with increasing salt concentrations (0.2M CaCl₂ followed by 1M NaCl) to release ionically bound cell wall proteins

  • Challenge: Contamination with cytoplasmic proteins

  • Solution: Include appropriate controls (cytoplasmic marker enzymes) to verify extraction purity

Detection optimization:

  • Challenge: Signal masking by abundant proteins

  • Solution: Perform fractionation or immunoprecipitation to enrich for MSD2 before detection

  • Challenge: Weak antibody binding under native conditions

  • Solution: Test multiple antibodies targeting different epitopes; optimize antibody concentration and incubation conditions

  • Challenge: Post-translational modifications affecting epitope recognition

  • Solution: Use multiple antibodies targeting different regions of the protein

Localization verification:

  • Challenge: Distinguishing cell wall from plasma membrane localization

  • Solution: Perform plasmolysis treatments before fixation to separate cell wall from plasma membrane

  • Challenge: Fixation-induced epitope masking

  • Solution: Test multiple fixation protocols and antigen retrieval methods

Research has confirmed MSD2's apoplastic localization using MSD2-mCherry fusions, demonstrating that the fluorescence signal remains associated with the cell wall after plasmolysis, clearly distinguishing it from plasma membrane localization .

How can researchers troubleshoot common issues with MSD2 antibody-based detection methods?

When troubleshooting MSD2 antibody applications, consider these methodological approaches:

Weak or absent signal:

  • Increase protein loading (50-100 μg for total extracts, consider apoplast enrichment)

  • Optimize antibody concentration through titration experiments

  • Extend primary antibody incubation time (overnight at 4°C)

  • Implement signal enhancement systems (amplified chemiluminescence)

  • Test different extraction buffers to improve MSD2 solubilization

  • Consider using tagged MSD2 constructs with highly specific tag antibodies

High background issues:

  • Increase blocking stringency (5% BSA or milk, extend blocking time to 2 hours)

  • Add 0.1-0.3% Tween-20 to washing buffers

  • Perform additional and longer wash steps

  • Pre-absorb antibodies with plant extracts from msd2 mutants

  • Reduce secondary antibody concentration

  • Use highly cross-adsorbed secondary antibodies

Non-specific bands:

  • Include genetic controls (msd2 mutants) to identify specific bands

  • Perform peptide competition assays to confirm band identity

  • Use gradient gels for better resolution

  • Test antibodies generated against different MSD2 epitopes

  • Consider using monoclonal antibodies for higher specificity

Inconsistent results:

  • Standardize protein extraction protocols

  • Prepare fresh working solutions for critical reagents

  • Maintain consistent transfer conditions

  • Include internal loading controls for normalization

  • Implement technical replicates (minimum three)

  • Document lot-to-lot variation in antibody performance

Research has demonstrated successful MSD2 detection using tag-based approaches (MSD2-mCherry) and native-PAGE combined with activity staining and immunoblotting , which can serve as positive controls when troubleshooting direct MSD2 antibody applications.

What considerations are important when developing new antibodies against MSD2 or its modified forms?

Developing effective antibodies against MSD2 requires careful planning and validation:

Antigen design strategies:

  • Analyze the MSD2 sequence to identify unique regions with low homology to other SOD family members

  • Consider developing antibodies against the signal peptide, which is unique to MSD2

  • For modification-specific antibodies, generate peptides containing specific modifications (e.g., nitrated Y68)

  • Use structural modeling to identify surface-exposed regions suitable for antibody generation

  • Consider the three-dimensional structure to avoid regions that might be inaccessible in the native protein

Production approaches:

  • For initial studies, develop polyclonal antibodies against multiple epitopes

  • For higher specificity, generate monoclonal antibodies against selected epitopes

  • Consider different host species to maximize compatibility with experimental systems

  • Purify antibodies against the immunizing peptide/protein to enhance specificity

  • For modification-specific antibodies, include extensive negative selection against unmodified peptides

Comprehensive validation:

  • Test reactivity against recombinant MSD2 and plant extracts

  • Verify specificity using msd2 mutant plants as negative controls

  • Assess cross-reactivity with related proteins, particularly MSD1

  • Perform immunoprecipitation followed by mass spectrometry identification

  • Validate across multiple applications (Western blot, IP, IHC, ELISA)

Application-specific optimization:

  • For Western blotting: Test under both reducing and non-reducing conditions

  • For immunoprecipitation: Optimize antibody concentration and binding conditions

  • For immunohistochemistry: Evaluate different fixation and antigen retrieval methods

  • For ELISA: Determine sensitivity, specificity, and working range

Structural analysis has revealed that Y68 in MSD2 is a key target for nitration, making it an excellent candidate for modification-specific antibody development . The distance between the Y68 side chain and the Mn²⁺ within the active site decreases upon nitration, providing a structural basis for the inhibitory effect of this modification .

How can MSD2 antibodies be used to study the impact of genetic modifications on protein expression and function?

Antibody-based approaches offer powerful tools for analyzing how genetic modifications affect MSD2:

Comparative expression analysis:

  • Compare MSD2 protein levels between wild-type, knockout, knockdown, and overexpression lines

  • Analyze expression patterns across different tissues and developmental stages

  • Assess how genetic modifications affect post-translational modifications

  • Correlate protein levels with transcriptomic data to identify post-transcriptional regulation

Structure-function studies:

  • Analyze how point mutations (e.g., Y68F) affect protein stability and expression levels

  • Determine the impact of signal peptide deletion on protein localization

  • Assess how domain-specific mutations affect interaction with other proteins

  • Correlate modifications in protein structure with changes in enzymatic activity

Subcellular distribution analysis:

  • Compare localization patterns between wild-type and modified MSD2 variants

  • Assess how deletion of the signal peptide affects trafficking (cytoplasmic accumulation vs. apoplastic localization)

  • Determine tissue-specific differences in localization patterns

  • Analyze whether point mutations affect protein trafficking or retention

Phenotypic correlation:

  • Connect molecular phenotypes (protein expression, localization, activity) with morphological phenotypes

  • Compare root elongation zones between wild-type and msd2 mutants under different light conditions

  • Analyze ROS distribution patterns in relation to MSD2 expression levels

  • Assess stress tolerance phenotypes in relation to MSD2 activity levels

Research has shown that deleting the signal peptide abolishes both apoplastic and vacuolar localization of MSD2-mCherry, resulting in cytoplasmic accumulation instead . Additionally, msd2 mutants exhibit increased elongation zone size in dark-grown seedlings due to increased cell number, suggesting MSD2 participates in skotomorphogenesis by limiting cell proliferation under dark conditions .

What methodological approaches enable the study of MSD2 interactions with other proteins using antibody-based techniques?

Understanding MSD2's interaction network requires specialized antibody-based approaches:

Co-immunoprecipitation strategies:

  • Immunoprecipitate MSD2 using specific antibodies under native conditions

  • Identify co-precipitating proteins via Western blotting or mass spectrometry

  • Perform reciprocal immunoprecipitation with antibodies against suspected interactors

  • Compare interaction profiles under different environmental conditions

  • Use crosslinking approaches to capture transient interactions

Proximity-based detection:

  • Implement proximity ligation assays to visualize protein-protein interactions in situ

  • Use bimolecular fluorescence complementation with antibody validation

  • Perform fluorescence resonance energy transfer (FRET) analysis with fluorescently tagged proteins

  • Correlate proximity data with co-immunoprecipitation results

  • Visualize interactions in different cellular compartments and tissue types

Functional interaction validation:

  • Assess how interacting proteins affect MSD2 enzymatic activity

  • Investigate whether interactions are modified by post-translational modifications

  • Determine if interactions change under stress conditions

  • Analyze phenotypes of mutants lacking putative interacting partners

Interaction mapping:

  • Use antibodies against different MSD2 domains to identify interaction interfaces

  • Perform deletion and point mutation analysis to map specific interaction sites

  • Develop domain-specific antibodies to block particular interaction surfaces

  • Correlate structural models with interaction data

While specific MSD2 protein interactions have not been extensively characterized in the available search results, the protein's role in ROS metabolism suggests potential interactions with NADPH oxidases, cell wall proteins, and other components of redox signaling pathways. The apoplastic localization of MSD2 indicates it likely interacts with extracellular proteins involved in cell wall development and stress responses .

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.